Leishmaniasis at the end of the millennium
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases
Link
http://link.springer.com/content/pdf/10.1007/s11908-999-0057-8.pdf
Reference38 articles.
1. Kumar R, Kumar P, Chowdhary RK, et al.: Kala-azar epidemic in Varanasi district, India. Bull WHO 1999, 77:371–374.
2. Pineda JA, Gallardo JA, Macias J, et al.: Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain. J Clin Microbiol 1998, 36:2419–2422. By performing bone marrow aspiration regardless of symptoms, these authors determined the prevalence of Leishmania species infection in a group of 291 HIV-positive persons in southern Spain. Amastigotes were found in 11% of patients; only 59% of the patients with amastigotes had symptoms attributable to visceral leishmaniasis. Persons with Centers for Disease Control and Prevention clinical category C were the most likely to have symptomatic visceral leishmaniasis. Symptomatic disease was also more prevalent in males than in females, and in intravenous drug users than in persons who were not intravenous drug users.
3. Lopez-Velez R, Perez-Molina JA, Guerrero A, et al.: Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain. Am J Trop Med Hyg 1998, 58:436–443. Of 54 HIV-positive persons, 24% died within 1 month of diagnosis of visceral leishmaniasis. Of those who responded to therapy, 61% had relapse within 1 year.
4. Khalil EA, el Hassan AM, Zijlstra EE, et al.: Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: management of those who do not respond. Ann Trop Med Parasitol 1998, 92:151–158.
5. Seaman J, Mercer AJ, Sondorp HE, Herwaldt BL: Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions with limited resources. Ann Intern Med 1996, 124:664–672.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Leishmaniasis–HIV coinfection: current challenges;HIV/AIDS - Research and Palliative Care;2016-10
2. New challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas;Drug Development Research;2011-09
3. Discovery of Novel Vaccine Candidates and Drug Targets Against Visceral Leishmaniasis Using Proteomics and Transcriptomics;Current Drug Targets;2008-11-01
4. Proteomic approaches for discovery of new targets for vaccine and therapeutics against visceral leishmaniasis;PROTEOMICS - Clinical Applications;2008-02-13
5. Reduced Pathology following Infection with Transgenic Leishmania major Expressing Murine CD40 Ligand;Infection and Immunity;2007-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3